Volume 3, Issue 1, January 2017, Page: 10-20
Antioxidant Properties of Aqueous Extract of Salvadora persica in Rats Subjected to Forced Swimming Test
Kholoud S. Ramadan, Department of Biochemistry, Faculty of Science-Al Faisaliah, King Abdulaziz University, Jeddah, Saudi Arabia
Hoda E. A. Farid, Department of Biochemistry, Faculty of Science-Al Faisaliah, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Biochemistry, Faculty of Agriculture, Minufiya University, Cairo, Egypt
Jummanah J., King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
Raya M. M. Almarashi, Department of Biochemistry, Faculty of Science-Al Faisaliah, King Abdulaziz University, Jeddah, Saudi Arabia
Received: Dec. 11, 2016;       Accepted: Jan. 13, 2017;       Published: Feb. 9, 2017
DOI: 10.11648/j.bs.20170301.13      View  2066      Downloads  76
Abstract
Salvadora persica (SP) has been used as a medicinal purpose among global Muslim community. The present study was carried out to evaluate the antioxidant activity of aqueous extract of SP in male albino rats subjected to forced swimming test (FST) and related biochemical parameters. These activities were tested at dose of 900 mg/kg extracts of SP administered orally for 28 successive days. Rats were divided into two groups (12 animals/group): control group (distilled water) and extract group (SP aqueous extract at 900 mg/kg for two weeks. On day 14, animals will be further classified into four equal groups (six animals each): Undepressed control, depressed rats, extract plus undepressed rats and extract plus depressed for next two weeks. The weight of the animals will be measured every week. HPLC analysis revealed the profile of SP extract. It was found that extract significantly (p<0.001) increases mobility time in rats. It also showed significant (p<0.001) decreased in blood glucose and DNA fragmentation as compared to depressed group. Additionally, there was an imbalance of oxidants/antioxidants level in brain of depressed rats and a significant inhibition on serum butyrylcholinesterase (BuChE) activity in rats exposed to FST. The obtained results revealed that SP extract has got significant antioxidant activity. Hence, aqueous extract of SP may be explored further for the management of mental depression.
Keywords
Salvadora persica, Depression, Force Swimming Test, DNA Fragmentation, Oxidative Stress
To cite this article
Kholoud S. Ramadan, Hoda E. A. Farid, Jummanah J., Raya M. M. Almarashi, Antioxidant Properties of Aqueous Extract of Salvadora persica in Rats Subjected to Forced Swimming Test, Biomedical Sciences. Vol. 3, No. 1, 2017, pp. 10-20. doi: 10.11648/j.bs.20170301.13
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
F. G. Elsaid, K. M Alzailaie, and A. A Shati, “Biochemical and Molecular Alterations Associated with Depression Induced in Rats,” Archives des sciences / éditées par la Société de physique et d'histoire naturelle de Genève, vol. 66 (1), pp. 134-154, 2013.
[2]
The world health report: Mental Health: new understanding new hope. WHO, Geneva, 2001.
[3]
E. H. Reynolds, “Brain and mind: A challenge for WHO,” Lancet Com, vol. 36, pp. 1924-1925, 2003.
[4]
P. Umadevi, S. Murugan, S. Jennifer Suganthi, and S. Subakanmani, “Evaluation of antidepressant like activity of cucurbita pepo seed extracts in rats,” International Journal of Current Pharmaceutical Research, vol. 3 (1), pp. 108-113, 2011.
[5]
H. Takeda, M. Tsuji, T. Yamada, J. Masuya, K. Matsushita, M. Tahara, M. Iimori, and T. Matsumiya T, “Caffeic acid attenuates the decrease in cortical BDNF mRNA expression induced by exposure to forced swimming stress in mice,” Eur. J. Pharmacol. vol. 534, pp. 115–121, 2006.
[6]
G. A. Carrasco, and L. D. VandeKar, “Neuroendocrine pharmacology of stress,” Eur. J. Pharmacol, vol. 463, pp. 235–272, 2003.
[7]
I. Niebroj-Dobosz, D. Dziewulska, and H. Kwiecinski, “Oxidative damage to proteins in the spinal cord in amyotrophic lateral sclerosis (ALS),” Fol Neuropa, vol. 42, pp. 151–156, 2004.
[8]
M. Kubera, E. Obuchowicz, L. Goehler, J. Brzeszcz, and M. Maes, “In Animal Models, Psychosocial Stress-Induced (Neuro) Inflammation, Apoptosis and Reduced Neurogenesis Are Associated to the Onset of Depression,” Prog. Neuropsychopharmacol. Biol. sychiatry, vol. 35, 3pp. 744-759, 2011.
[9]
A. Shati, F. G. Elsaid, and E. E. Hafez, “Biochemical and molecular aspects of aluminium chloride-induced neurotoxicity in mice and the protective role of Crocus sativus L. extraction and honey syrup,” Neurosci, vol. 175, pp. 66-74, 2011.
[10]
J. Greilberger, C. Koidl, M. Greilberger, M. Lamprecht, K. Schroecksnadel, F. Leblhuber, et al “Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease,” Free Radic. Res, vol. 42 (7), pp. 633– 638, 2008.
[11]
S. Darvesh, D. A. Hopkins, and C. Geula, “Neurobiology of butyrylcholinesterase”, Nat Rev Neurosci, vol. 17, pp. 131–138, 2003.
[12]
J. Massoulie, L. Pezzementi, S. Bon, E. Krejci, and F. M. Vallette, “Molecular and cellular biology of cholinesterases”, Prog Neurobiol, vol 41 (1), pp. 31–91, 1993.
[13]
M. M. Mesulam, A. Guillozet, P. Shaw, A. Levey, E. G. Duysen, and O. Lockridge, “Acethylcolynesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyse acetylcholine,”Neuroscience, vol. 110, pp. 627–639, 2002.
[14]
V. M. Alcantara, E. A. Chautard-Freire-Maia, M. Scartezini, M. S. Cerci, K. Braun-Prado, and G. Picheth, “Butyrylcholinesterase activity and risk factors for coronary artery disease,” Scan J Clin Lab Invest, vol. 62, pp. 399–404, 2002.
[15]
A. K. Johnson, A. J. Grippo, “Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression,” J Physiol Pharmacol, vol. 57 (S11), pp. 5–29, 2006.
[16]
B. Halliwell, “Dietary polyphenols: Good, bad, or indifferent for your health”? Cardiovasc. Res, vol. 73, pp. 341-347, 2007.
[17]
B. Dimitrios, “Sources of natural phenolic antioxidants.” Trends Food Sci. Technol, vol. 17, pp. 505-512, 2006.
[18]
H. S. Abdillahi, G. I. Stafford, J. F. Finnie, and J. V. Staden, “Ethnobotany, phytochemistry and pharmacology of Podocarpus sensus”, South Afr J Bot, vol. 76 (1), pp. 1-24, 2010.
[19]
J. Sarko, “Antidepressants, old and new. A review of their adverse effects and toxicity in overdose”, Emerg. Med. Clin. North Am, vol. 18, pp. 637–654, 2000.
[20]
F. S. Badruddeen, H. Siddiqui, and S. Haque, “Psychoimmunomodulatory activity of Salvadora persica L. (Miswak) extract on stress model in rats”, Asian Journal of Traditional Medicines, vol. 7 (3), pp. 109–117, 2012.
[21]
Y. Zuo, H. Chen and Y. Deng, “Simultaneous Determination of Catechins Caffeine and Gallic acids in Green, Oolong, Black and Pu-err Teas using HPLC with a Photodiode Array Detector”, Talanta, vol. 57, pp. 307-316, 2002.
[22]
P. Goupy, M. Hugues, P. Biovin and M. J. Amiot, “Antioxidant composition and activity of barley (Hordeum Vuigare) and malt extracts and of isolated phenolic compounds”, J. Sci. Food Agric, vol. 79, pp. 1625 -1634, 1999.
[23]
M. Romeu-Nadal, S. Morera-Pons, A. I. Castellote and M. C. Lopez-Sabater, “Rapid high-performance liquid chromatographic method for Vitamin C determination in human milk versus an enzymatic method,” Jornal of Chromatography B, vol. 830, pp. 41-46, 2006.
[24]
R. D. Porsolt, “Depression: a new animal model sensitive to antidepressant treatments.” Nature, vol. 266, pp. 730- 732, 1977.
[25]
I. Lucki, “The forced swimming test as a model for core and component behavioral effects of antidepressant drugs”, Behav. Pharmacol, vol. 8, pp. 523–532, 1997.
[26]
K. Burton, “A study of the conditions and mechanisms of thediphenylamine reaction for the estimation of deoxyribonucleic acid”, Biochem. J, vol. 62, pp. 315–323, 1956.
[27]
C. E. Perandones, V. A. Liiera, D. Peckham, L. L. Stunz and R. F. Ashman, “Regulation of apoptosis in vitro in mature spleen T-cell,” J. Immunol, vol. 151, pp. 3521-3528, 1993.
[28]
D. Koracevic, G. Koracevic. et al. “Method for the measurement of antioxidant activity in human fluids,” J. clinic. Pathol, vol. 54 (5), pp. 356, 2001.
[29]
H. Aebi, “Catalase in vitro”, Methods Enzymol, vol. 105, pp. 121–126, 1984.
[30]
D. M. Goldberg, and R. J. Spoone, “In Methods of Enzymatic Analysis” (Bergmeyen, H. V. Ed.) 3rd ed. Vol. 3, pp 258-265, 1983.
[31]
H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction”, Anal Biochem, vol. 95, pp. 351–358, 1979.
[32]
A. C Gornal, C. J. Bardawill, and M. M. David, J. Biol. Chem vol. 177, pp. 751, 1949.
[33]
H. Weber, “Serum cholinesterase concentration,” Deutsch Med. Wschr, vol. 91, pp. 1927-1932, 1966.
[34]
G. Hao, C. Zhang, W. Cao, and J. Hao, “Effects of intragastric administration of five oyster components on endurance exercise performance in mice,” Pharmaceutical Biology, vol. 52, no. 6, pp. 723–728, 2014.
[35]
V. D. Bokkenheuser VD, “Hydrolysis of dietary flavanoid glycosides by strains of intestinal bacteroides from humans,” Biochemical Journal, vol. 248, pp. 953- 956, 1987.
[36]
T. Walle, “Absorption and metabolism of flavonoids”, Free Radical Biology and medicine, vol. 36 (7), pp. 829- 837, 2004.
[37]
K. A. Youdim, “Corrigendum to flavanoid permeability across as in situ model of the blood brain barrier”, Free Radical Biology and Medicine, vol. 36, pp. 592- 604, 2004.
[38]
K. A. Youdim, “Dietary flavanoids as potential neuroprotectants,” The Journal of Biological Chemistry, vol. 383, pp. 503- 519, 2002.
[39]
H. M. Osman, M. E. Shayoub, and E. M. Babiker, “The effect of Moringa oleifera leaves on blood parameters and body weights of albino rats and rabbits,” Jordan Journal of Biological Sciences, vol. 5, no. 3, pp. 147–150, 2012.
[40]
R. McArthur and F. Borsini, “Animal models of depression in drug discovery: A historical perspective”, Pharmacol. Biochem. Behav, vol. 84, pp. 436–452.
[41]
B. Petit-Demouliere, F. Chenu, and M. Bourin, “Forced swimming test in mice: A review of antidepressant activity”, Psychopharmacology, vol. 177, pp. 245–255, 2005.
[42]
C. E. Renard, E. Dailly, D. J. David, M. Hascoet, M. Bourin, “Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test”, Fundam. Clin. Pharmacol, vol. 17, pp. 449–455, 2003.
[43]
M. Tanaka, F. Nakamura, S. Mizokawa, A. Matsumura, S. Nozaki, and Y. Watanabe, “Establishment and assessment of a rat model of fatigue,” Neuroscience Letters, vol. 352, no. 3, pp. 159–162, 2003.
[44]
E. H. Choi, J. Kang, J. Y. Cho et al., “Supplementation of standardized lipid-soluble extract from maca (Lepidium meyenii) increases swimming endurance capacity in rats,” Journal of Functional Foods, vol. 4, no. 2, pp. 568–573, 2012.
[45]
D. M. Kannur, A. A. Kulkarni, M. P. Paranjpe, and M. V. Navangul, “Screening of antistress properties of herbal extracts and adaptogenic Agents”, Pharmacognosy Reviews, vol. 2, no. 3, pp. 95-101, 2008.
[46]
M. Sumanth, and S. S. Mustafa, “Antistress, adoptogenic and immunopotentiating activity roots of Boerhaavia diffusa in mice”, International Journal Pharmacology, vol. 3, no. 5, pp. 416-420, 2007.
[47]
M. Sumanth, and S. S. Mustafa, “Antistress, adoptogenic activity of Sida cordifolia roots in mice”. Indian Journal of Pharmaceutical Science, vol. 71, no. 3, pp. 323-324, 2009.
[48]
B. V. S. Lakshmi, and M. Sudhakar, “Screening of Psidium guajava leaf extract for antistress activity in different experimental animal models”, Pharmacognosy Research, vol. 1, no. 6, pp. 359-366, 2009.
[49]
M. Arora and V. K. Gupta, “Phytochemical and biological studies on Salvadora persica wall: review,” Pharmacologyonline, vol. 1, pp. 591–601, 2011.
[50]
S. Lanjhiyana, D. Garabadu, D. Ahirwar et al., “Antidiabetic activity of methanolic extract of stem bark of Elaeodendron glaucum Pers. in alloxanized rat model,” Journal of Advertising and Applied Science Research, vol. 2, no. 1, pp. 47–62, 2011.
[51]
K. S. Ramadan, H. E. A. Farid and R. M. M. Almarashi, “Antidepressant-like Effects of Aqueous Extract of Salvadorapersica in Rat Model of Depression”, J Diabetes & Metabolism, vol. 7, no. 8, pp. 1-5, 2016.
[52]
R. C. Duke, and J. J. Cohen, “The role of nuclear damage in lysis of targetbcell by cytotoxic T lymphocytes”. In: cytolytic lymphocytes and complement: Effectors of the immune system. E. R. Podak, ed. CRC press, Boca Raton, FL, pp. 35-37, 1988.
[53]
B. Schaller, and R. Graf, “Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy”, J. Cerebral Blood Flow Metabol, vol. 24, no. 4, pp. 351–371, 2004.
[54]
M. Maes, R. Yirmya, J. Noraberg, S. Brene, J. Hibbeln, G. Perinii, M. Kubera, P. Bob, B. Lerer, and M. Maj, “The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression”, Metab Brain Dis, vol. 24, vol. 27–53, 2009.
[55]
S. A. Saeed, K. F. Shad, T. Saleem, F. Javed, and M. U. Khan, “Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke”, Exper. Brain Res, vol. 182, no. 1, pp. 1–10, 2007.
[56]
M. E. Ozcan, M. Gulec, E. Ozerol, R. Polat, and O. Akyol, “Antioxidant enzyme activities and oxidative stress in affective disorders”, Int. Clin. Psychopharmacol, vol. 19, pp. 89–95, 2004.
[57]
C. Matte´, V. Mackedanz, F. M. Stefanello, E. B. Scherer, A. C. Andreazza, C. Zanotto, et al. “Chronic hyperhomocysteinemia alters antioxidant defenses and increases DNA damage in brain and blood of rats: protective effect of folic acid”, Neurochem Int, vol. 54, no. 1, pp. 7–13, 2009.
[58]
H. Takeda, M. Tsuji, M. Inazu, T. Egashira, and T. Matsumiya, “Rosmarinic acid and caffeic acid produce antidepressive-like effect in the forced swimming test in mice”, European J. Pharmacol, vol. 449, pp. 261–267, 2002.
Browse journals by subject